A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...